An Aspirin A Day Keeps the First Heart Attack Away… N...
December 1, 2021 - Featured , In the News / Politics By: Jun Suh Hong, PharmD candidate c/o 2022 Aspirin belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDS). Known by many for its analgesic and anti-inflammatory properties, as well as its association with gastrointestinal (GI) bleeding, aspirin plays an essential role in stroke prevention. As such, it has a crucial role in… |
|
An Overview of Ketamine Cystitis...
December 1, 2021 - Clinical , Featured By: Pallak Sharma, PharmD Candidate c/o 2022 and Mia Cord-Cruz, PharmD Candidate c/o 2022 Ketamine (Ketalar®) is currently approved by the Food and Drug Administration (FDA) for use as a general anesthetic, with additional indications listed within its package insert.1 Ketamine is a highly abused “street drug”, especially in China. To demonstrate, in Hong… |
|
Cabenuva: A Monthly Injectable for the Treatment of HIV...
December 1, 2021 - Featured , In the News / Politics By: Sharon Joseph PharmD Candidate c/o 2022 and Salma Hewady, PharmD Human immunodeficiency virus (HIV) is a single-stranded retrovirus that attacks the immune system, predisposing the host to opportunistic infections and malignancies. If not properly treated, HIV can progress to Acquired Immunodeficiency Syndrome (AIDS). Goals of therapy include restoration of immune function, suppression of… |
|
Combating Chronic Diseases with a Plant-Based Diet...
December 1, 2021 - Clinical , Featured By: Ashely Dao, PharmD Candidate c/o 2024 In early 2021, about 6 in 10 American adults had a chronic disease. Chronic diseases are the leading cause of death and disability in the United States with 1 in 3 deaths caused by cardiovascular diseases (CVD).¹ The Coronavirus disease 2019 (COVID-19) pandemic has emphasized the impact… |
|
Good News, Bad News about Novel Treatment Resistant Dep...
December 1, 2021 - Featured , In the News / Politics By: Daniel Levin, PharmD candidate c/o 2022 Depression is a terrible beast of an illness to battle with, and there are nearly 14 million individuals at any given moment fighting it. Only around 50% of patients struggling with depression will get some form of treatment. Sixty to seventy percent of patients who do get… |